The monoclonal antibody is directed against the CD5-antigen (T1-antigen), which is expressed on human T lymphocytes. The nonoclonal antibody reacts with 90% of human peripheral T lymphocytes, medullary thymocytes as well as with lymphocytes of patients with chronic B-cell derived leukaemia.